Existing treatments don’t extend life for HFpEF patients

Thanks! Share it with your friends!

Close

NEW YORK (Reuters Health) – Drugs currently available for patients with heart failure with preserved ejection fraction (HFpEF) have no mortality benefit, acc…

Comments

Write a comment

*

 
Share This Page On:
 
Delicious
powered by: AbhiD.org